Skip to content
Stay informed with the latest UK health news, medical break…

Providing Stem Cells in Utero to Babies with Neural Tube Defect Boosts Quality of Life, Trial Finds

An innovative clinical study has revealed that delivering regenerative cells to fetuses suffering from spina bifida during corrective surgery can be a "major milestone" in addressing congenital conditions.

Study Parameters and Security

The research conducted in the United States involved six fetuses with the 'open' form of spina bifida. Surgeons applied regenerative cells sourced from the maternal placenta on the exposed area of the infant's spine during the repair procedure.

Importantly, the stem cell application was found to be safe. The study team reported that the therapy did not induce cancerous growths, interfere with wound healing, or block the correction of associated brain abnormalities.

Positive Developments

Post-birth MRI scans showed a successful correction of brainstem displacement in every participant. This favorable anatomical change is a key indicator for improved motor skills and quality of life.

"Should it enable additional babies able to walk who previously could not, then it would become the new treatment paradigm," noted the study director. "The results are super exciting and create a pathway toward lots of potential new treatments."

Future Implications and Hope

Independent medical specialists proposed that additional validation of these observed advantages could herald a "different age" in prenatal intervention. The possibility of ameliorating neurological damage present before birth is viewed as a paradigm-shifting aim.

Notably important would be better management of urogenital and gastrointestinal outcomes, which are common challenges for those diagnosed with this condition.

Looking Ahead

While this initial trial focused on a handful of cases, its confirmed tolerability and hopeful trends create a solid basis for expanded clinical research. The addition of cellular treatment with established fetal surgery techniques holds considerable promise for transforming outcomes for future generations with this neural tube defect.

About the author

Gilbert Braun

A UK-based health journalist with over a decade of experience covering medical trends and public health issues.

Pulse Today Hub

Type to search articles.